2nd European Conference on

Gynecology, Obstetrics & Reproductive Health

Theme: Techniques and Innovation in Field of Women Health, Pregnancy and Delivery

Event Date & Time

Event Location

Paris, France

18 years of lifescience communication

14422635477

Previous Conference Performers / Professionals From Around The Globe

Tracks & Key Topics

Euro Gynecology 2019

About Conference

Euro Gynecology 2019
 
The EuroSciCon is a renowned organization that organizes highly momentous conferences throughout the globe. Currently, we are bringing fifth “EuroSciCon Conference on Gynecology, Obstetrics & Reproductive Health " scheduled to be held during June 7-8, 2019 at Paris, France. The conference highlights the theme "Technical Strategies in Pre-natal grief, Child Birth and Congenital Disorders".
 
Euro Gynecology 2019 conference is the platform to discuss various disciplines involved in the with women's complaints— Gynecologic Surgery, Gynecological Diseases, Fertility, Pregnancy, Contraception, Family Planning, Gynecology & Obstetrics, Menopause, Women Reproductive Cancers, Abortion and Women Health, Ethical Legal and Social Issues, Cosmetic Gynaecology and Stem Cells in Obstetrics and Gynecology etc. Gynecology is the medical practice dealing with the health of the female reproductive systems (vagina, uterus, and ovaries) and the breasts. Almost all modern gynaecologists are also obstetricians.
 
Why to attend??
The scientific program includes Keynote & Plenary talks, Video Presentations, Poster Presentations and E-Posters. Furthermore, oral communications of (post) doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, and receive name recognition in this 2-day event. It is an idiosyncratic Opportunity for Advertisers and Sponsors at this International event.
The Euro Gynecology 2019 highlights the evolving strategies and conditions deals with the infertility, menopause, abortion & women health, child birth, care, ethical legal and social issue, ultrasound and genetics & gynecological cancer.
 
What’s New
Euro Gynecology 2019 Conference conducts presentations; distribute information, throughout the world where we can meet with current and potential professors, researches, scientists. Scientific events are the specially designed cluster of the program that provides a common platform where industry meets academia to discuss the recent issues and happening. It serves as a bridge between researchers from academia and industry enhanced by its well organized scientific sessions, plenary lectures, poster presentations, world-class exhibitions, diverse symposiums, highly enriched workshops and B2B meetings.
 
About Venue
Paris is without a doubt one of the most beautiful cities in the world, and the capital of France. Paris is famous for the art of fashion. There are a million things to do and see in Paris and no matter how long you plan to learn French there, it'll never be long enough: Climb to the top of the Eiffel Tower, walk down the Avenue Champs Elysees, visit the Louvre Museum, go to Euro Disney, enjoy the parks, gardens, boutiques. The Paris Region had the third-highest GDP in the world and the largest regional GDP in the EU. The football club Paris Saint-Germain and the rugby union club Stade Français are based in Paris. The 80,000-seat Stade de France, built for the 1998 FIFA World Cup, is located just north of Paris in the neighbouring commune of Saint-Denis. The city is a major rail, highway, and air-transport hub served by two international airports: Paris-Charles de Gaulle (the second busiest airport in Europe after London Heathrow Airport with 69.5 million passengers in 2017) and Paris-Orly. Paris is the capital city of France as well as its most populous one. Being the 3rd most visited city in the world, there are lots of Things to do in Paris. Founded in the 3rd Century BC, Paris is best known as the home to various most visited museums in the world.
Here is a list of the most beautiful places in Paris you will definitely want to visit. The Louvre Museum, Notre Dame Cathedral, The Eiffel Tower, Musée d’Orsay, The Sorbonne and the Latin Quarter, Arc de Triomphe and the Champs-Elysées, Boat Tour of the Seine River, Luxembourg Palace and gardens, Bois de Boulogne and Disneyland Parisg etc.
 
Target Audience:
Business delegates
Industrial Leaders
Researchers
Modern gynaecologists
Eminent personalities
Reputed scientists
Professors and Students from Academia
Doctors
Nurses
Nurse Practitioners
Students
Integrated Health Professionals
Industry Professionals
Health Promoters
 
EuroScicon is corporate members of the following organisations:
IBMS
Rare Care UK
Royal Society of Biology
British Society for Immunology
Opportunities for Conference Attendees

Session/ Tracks

Track1: Advances in Obstetrics and Gynecology
 
FDA warns against use of laser-type devices for vaginal cosmetic improvement or treatment of genitourinary symptoms of menopause, Microinsert for hysteroscopic sterilization to be removed from the US market in 2019, Safety of pregnancy termination by type of outpatient facility, Post discharge opioid requirements after surgery, Choice of transvaginal apical prolapse repair, Risk of occult malignancy at hysterectomy, Incidence of gender-affirming surgery among inpatients with transsexualism or gender identity disorder, Adverse outcomes associated with hysteroscopy sterilization, Ovulation induction in polycystic ovary syndrome: Letrozole is preferred agent (July 2018), Maternal subclinical hypothyroidism and childhood neurodevelopmental outcomes etc are recent advances in obstetrics and gynecology.
 
Track2: Clinical Gynecologic Oncology
 
Gynecologic oncologists offer an integrated approach to the diagnosis and surgical management of women's cancers and complex benign gynecologic diseases. These include cervical cancer, endometriosis, fibroids, ovarian cancer, pelvic masses, uterine cancer, vaginal cancer and vulvar cancer. At the point when these malignancies were analyzed at their initial stages, the treatment will be more efficient. The Global Gynecological Cancer Drugs Market size was valued at $9,300 million in December 2016 and is expected to reach $16,125 million by 2024, growing at a CAGR of 8.5% from 2017 to 2024.
 
Track3: Gynecologic Cancers: Case Report
 
There we kept two case report of gynaecology cancer, 1) 80-year-old female was diagnosed with ovarian cancer in March 2004. Following gynecological surgery, pathological evaluation showed stage IIIC epithelial ovarian cancer. From March 2004 to January 2005, the patient received six cycles of conventional treatment combined with intravenous paclitaxel (Taxol®) and cisplatin. The patient developed abdominal distension and experienced a gradual deterioration in health during 2007, with admission to The First Affiliated Hospital in May 2007. 2) 53-year-old woman comes in for her first visit. She is an immigrant from South Africa who has lived in the United States for 6 years and has not had regular health care. Her past medical history is notable for hypertension and osteoarthritis. She takes no medications. She is married with six children; her husband is a long-haul truck driver. Her first sexual contact was at age 15, and she has had five partners in her lifetime. She has been smoking one pack of cigarettes per day for the last 31 years. She reports vaginal spotting after intercourse, which she thinks is related to vaginal dryness after menopause.
 
Track4: Gynecologic Surgery
 
Gynecological surgery refers to surgery on the female reproductive system. Gynecological surgery is usually performed by gynecologists. It includes procedures for benign conditions, cancer, infertility, and incontinence. Gynecological surgery may occasionally be performed for elective or cosmetic purposes. If you need treatment for fibroids, ovarian cysts, endometriosis or other gynecologic conditions, minimally invasive gynecologic surgery may be a good option. Performed by specially trained surgeons, this advanced procedure often causes less pain, leave smaller scars, heal more quickly and carry a lower risk of infection. The global gynecology devices market size was valued at USD 8.0 billion in 2017 and is expected grow at a CAGR of 16% during the forecast period.
 
Track5: Gynecological Endocrinology
 
Reproductive endocrinology is a surgical subspecialty of obstetrics and gynecology that trains physicians in reproductive medicine addressing hormonal functioning as it pertains to reproduction as well as the issue of infertility. A gynecological endocrinologist, more commonly called a reproductive endocrinologist, is a doctor who specializes in the treatment of disorders related to fertility, menstruation and menopause. The global infertility treatment market is expected to rise at a CAGR of 10.8% during the forecast period 2016-2024.
 
Track6: Health-Related Behaviours and Changes in Women
 
Behavioural health is stated as the issues that can have a different outcome by changing behaviour. For example, giving up smoking can lessen the illnesses or Health Problems associated with cigarette smoking as discussed in many gynecologic conferences and gynecologic meetings worldwide. Many health conditions are caused by risk behaviours, such as, smoking, reckless driving, problem drinking, substance use, overreacting, or unprotected sexual intercourse. Fortunately, human beings have control over their conduct. Health-compromising behaviours can be eradicated by self-regulatory efforts and health enhancing behaviours that can be adopted such as preventive nutrition, physical exercise, weight control, dental hygiene, and condom use or accident prevention.
 
Track7: Gynecologists & Obstetricians Market Research Report
 
Healthcare industries have experienced strong growth over the past six years, the Gynecologists and Obstetricians industry have grown at a more muted pace. While demand for most healthcare services is based mainly on access to health insurance, OB-GYN services have such a necessary place in women's health that demand is steady for this industry. In the global gynecology surgical instruments industry market analysis & forecast 2018–2022, the revenue is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2018 and 2022. The production is estimated at XX million in 2018 and is forecasted to reach XX million by the end of 2022, growing at a CAGR of XX% between 2018 and 2022.
 
Track8: Infertility
 
Infertility is the inability of a person, animal or plant to reproduce by natural means. It is usually not the natural state of a healthy adult, except notably among certain asocial species the fertility in the US to grow at steadily a CAGR of around 5% by 2020. The fertility market in the US consists of fertility drugs and assisted reproductive technology (ART) services segments. Increasing fertility issues among the ageing population, rising disposable income, growing adoption of fertility services by homosexual couples, and augmented support from the US federal government are some of the major factors that will impel growth in this market during the forecast period. The global infertility treatment market is expected to rise at a CAGR of 9.6% during the forecast period 2016-2020.
 
Track9: Family Planning
 
Family planning as defined by the United Nations and the World Health Organization encompasses services leading up to conception and does not promote abortion as a family planning method, although levels of contraceptive use reduce the need for abortion. Family planning is sometimes used as a synonym or euphemism for access to and the use of contraception. However, it often involves methods and practices in addition to contraception. Some birth control methods use hormones. They will have either both an estrogen and a progestin or a progestin alone. Over the five years to 2018, the Family Planning and Abortion Clinics industry experienced increasing demand, as an increase in the number of people with health insurance & over the five years to 2023, industry revenue is projected to grow.
 
Track10: Male Reproductive Cancers
 
Prostate cancer is the most common male cancer in the UK, accounting for 25% of all new male cancers. Age related, the incidence rises sharply from 50 years of age with the highest incidence in those 75-80 years and higher incidence in men of Afro-Caribbean descent. If a tumour starts to develop on active surveillance or is thought to be intermediate/high risk localised disease, surgical removal of the prostate may be advised.  Surgery is the main treatment for penile cancer where the tumours are very small this may be laser surgery or cryosurgery. Global revenues for the urological cancer market are forecast to grow at a Compound Annual Growth Rate of 10.40%, from $18 billion in 2015 to $36 billion in 2022.
 
Track11: Gynecology & Obstetrics
 
Gynecology & Obstetrics is the medical and surgical speciality that focuses on the research prospectus of the reproductive system in females. Gynecology & Obstetrics focuses on its commitment to excellence in both patient care and convenience. With eleven providers/specialists in women’s health, our group offers services that are generally not found in all Ob/Gyn groups. As a result, in 2018, wages are expected to account for 47% of industry revenue, while depreciation costs are expected to account for 1.4%.
 
Track12: Menopause
 
The menopause is when a woman stops having periods and is no longer able to get pregnant naturally. Menopause is the process through which a woman ceases to be fertile or menstruate. It is a normal part of life and is not considered a disease or a condition. The menopause is a natural part of ageing that usually occurs between 46 and 55 years of age, as the woman's oestrogen levels decline. In the UK, the average age for a woman to reach the menopause is 5.
 
Track13: Midwifery
 
Midwifery, also known as obstetrics, is the health science and the health profession that deals with the reproductive genecology that includes pregnancy, childbirth, and the postpartum period besides sexual and reproductive health of women throughout their lives. Midwifery-led continuity of care is where one or more midwives have the primary responsibility for the continuity of care for childbearing women, with a multidisciplinary network of consultation and referral with other healthcare providers. The actual duties of the midwife in obstetrics and genecology associates categories include antiquity consisted mainly of assisting in the birthing process, although they may also have helped with other medical problems relating to women when needed. These midwives are registered nurses who have completed a nationally accredited graduate level program of study approved by the Accreditation Commission of Midwifery Education to become midwives. These midwives are not required to have health backgrounds before studying midwifery. Their education is usually a year or so in length after which they study as apprentices under other CPM’s or CNM's for experience. They achieve certification in midwifery through a different national exam, given by the North American Registry of Midwives. CPM’s tend to practice in out-of-hospital births, while CNM’s and CM’s often practice in hospitals but also attend birth Centre and home births. 94% of births by CNM’s occur in hospital.
 
Track14: Reproductive Medicine
 
Reproductive medicine is a branch of medicine that deals with prevention, diagnosis and management of reproductive problems; goals include improving or maintaining reproductive health and allowing people to have children at a time of their choosing. It is founded on knowledge of reproductive anatomy, physiology, and endocrinology, and incorporates relevant aspects of molecular biology, biochemistry and pathology. Europe is expected to emerge as a leading revenue contributor by 2022, with growth supported by the growing prevalence of infertility and rising demand for medical tourism. The fertility services market is expected to reach USD 9.8 billion by 2022.
 
Track15: Sexual and Reproductive Health and Rights
 
Sexual and reproductive health and rights or SRHR is an interpretation of human rights applied to sexuality and reproduction. Women’s sexual and reproductive health is related to multiple human rights, including the right to life, the right to be free from torture, the right to health, the right to privacy, the right to education, and the prohibition of discrimination. Reproductive rights rest on the recognition of the basic right of all couples and individuals to decide freely and responsibly the number, spacing and timing of their children and to have the information and means to do so, and the right to attain the highest standard of sexual and reproductive health.
 
Track16: Women Reproductive Cancers
 
Cancers can occur in any part of the female reproductive system—the vulva, vagina, cervix, uterus, fallopian tubes, or ovaries. These cancers are called gynecologic cancers. A risk factor is the chance that something will harm or otherwise affect a person’s health. There are different risk factors that can increase the chances of developing female reproductive cancers. Having a risk factor does not mean that you will develop cancer. Some risk factors cannot be changed, such as age, family history, and your genetic makeup, while others are related to factors in the environment that may cause cancer. Some risk factors can be changed through your health habits. According to the report, global ovarian cancer market was valued at approximately USD 1.86 billion in 2018 and is expected to generate revenue of around USD 4.10 billion by end of 2024, growing at a CAGR of around 11.83% between 2018 and 2024.
 
Track17: Ultrasound and Genetics
 
Genetic Ultrasound also referred to as Genetic Sonography, is a technique in which physical features of the fetus are examined to detect whether there are at increased risk for Down syndrome, or other chromosomal abnormalities. In addition to Down syndrome, Genetic Ultrasound identifies other birth defects such as spinal Bifida. There are various kinds of ultrasound which can be done during pregnancy namely Transvaginal Ultrasound, 3-D Ultrasound, 4-D Ultrasound and Fetal Echocardiography. While the Sonography reports in the first trimester provides information about the fetal heartbeat, it also, examines the placenta, uterus, ovaries, cervix, checks for multiple pregnancies, the sonography done in the second and third trimester reveals much important criteria like placental abruption, placenta previa, characteristics of Down’s syndrome if there are many possibilities.
 
Track18: Assisted Reproductive Technology
 
Assisted reproductive technology (ART) is used to treat infertility. It includes fertility treatments that handle both a woman's egg and a man's sperm. Assisted reproductive technology (ART) has enabled millions of infertile couples worldwide to have children. ART refers to the manipulation of eggs, sperm and embryos outside the body in order to achieve a pregnancy. The most common complication of ART is multiple pregnancies. It can be prevented or minimized by limiting the number of embryos that are put into the woman's body. Intrauterine insemination (IUI), which involves only the manipulation of sperm, is considered by some but not all as a type of ART. The global assisted reproductive technology market size was estimated to be around USD 20 billion in 2017 and is anticipated to grow at a CAGR of 12% over the forecast period. The global assisted reproductive technology (ART) market is expected to reach USD 45 billion by 2024.
 
Track19: Abortion and Women Health
 
An abortion is the termination of a pregnancy. A person can choose the abortion pill, given at the clinic, or they may choose the procedure performed at the clinic. Approximately 1.4 million women have an abortion per year, and 90% are in the first trimester of pregnancy. Less than 1% of abortions result in serious complications. First trimester abortion is considered minor surgery. The risk of complications for the woman increases with advancing gestational age. Altogether, these causes account for 80 percent of all deaths relating to a woman's pregnancy. Unknown or uncommon causes account for the remaining 20 percent of deaths relating to pregnancy. Women who have chronic severe diseases are at greater risk of death than are healthy women.            
 
Track20: Ethical Legal and Social Issues
 
Over the past decade, many ethical, legal, and social implications (ELSI) associated with genetic testing and researches have been raised. In order for genetic testing to be used safely and appropriately, these issues should be discussed with patients so that they are aware of risks and benefits. Genetic information is routinely used to inform reproductive decisions and medical care. Genetic information can raise questions about personal responsibility, personal choice versus genetic determinism/fate, and concepts of health and disease. Several issues regarding test validity should be considered prior to ordering a genetic test. When considering genetic testing, a major concern often raised is the potential for discrimination based on genetic information. To protect patients from additional distress, health care providers should be aware of the relevant ethical, legal, and social issues related to genetics in health care.
 
Track21: Prenatal Diagnosis of Chromosomal Abnormalities
 
Prenatal diagnosis of chromosomal anomalies employs a variety of techniques either as a screening procedure for relatively prevalent disorders or as a diagnostic procedure for known familial conditions. There are a variety of non-invasive and invasive techniques available for prenatal diagnosis. Each of them can be applied only during specific time periods during the pregnancy for greatest utility. The most common reason for prenatal diagnosis of chromosome abnormalities is to look for evidence of trisomies, Turner syndrome and triploidy. Screening technology held the majority of the market share with USD 2193.8 million and is anticipated to show robust growth with a CAGR of 12% in the forecast year. Downs Syndrome holds around more than 50% market share of prenatal and new-born genetic testing market and will show a robust growth over the forthcoming years. U.S. dominated the prenatal and new-born genetic testing market in the year 2017 with a market share of USD 2004.3 million, covering around more than fifty per cent of the market share.
 
Track22: Polycystic Ovary Syndrome
 
Polycystic ovary syndrome is a common condition that affects the woman’s ovaries work. Polycystic ovaries contain a large number of harmless follicles that are up to 8mm in size. PCOS is also associated with an increased risk of developing health problems in later life, such as type 2 diabetes and high cholesterol levels. The global polycystic ovarian syndrome treatment market size was valued at USD 3.8 billion in 2017 and is expected to grow at a CAGR of 5.1% over the forecast period. The global polycystic ovarian syndrome treatment market is expected to reach USD 5.1 billion by 2024. According to the Centres of Disease Control & Prevention, Polycystic Ovary Syndrome (PCOS) is the most common cause of female infertility. Thus, early diagnosis and effective treatment are significant for a successful recovery.
 
Track23: Medicated Intrauterine Device Market
 
An intrauterine device, also known as intrauterine contraceptive device or coil is a small, often T-shaped birth control device that is inserted into a woman's uterus to prevent pregnancy. IUDs are one form of long-acting reversible birth control. Most copper IUDs have a plastic T-shaped frame that is wound around with pure electrolytic copper wire and/or has copper collars (sleeves). The arms of the frame hold the IUD in place near the top of the uterus. Hormonal IUDs (brand names Mirena, Skyla, Kyleena, and Liletta; referred to as intrauterine systems in the UK) work by releasing a small amount of levonorgestrel, a progestin. The global intrauterine contraceptive devices market is expected to register a CAGR of 11% during the forecast period of 2018-2024.
 
Track24: Cosmetic Gynecology
 
Cosmetic gynaecology aims to make improvements to either the physical appearance or function of the vagina and labia; in many cases, both goals are accomplished simultaneously. A vaginoplasty procedure focuses on reducing the width of the vagina. Labiaplasty addresses the size and shape of the labia or the folds of skin that frame the opening of the vagina, a labiaplasty procedure may remove excess skin from both sides of the labia to reduce overall size, or from only one side to correct an asymmetry. Hymenoplasty is done to repair the tissue and restore the appearance of an intact hymen. In 2018, the botox injection market by procedure numbers is estimated to dominate the market with 33.3% shares and will collect around 25,431,093 aesthetic services by 2025, rising with the CAGR of 7.7%. The global cosmetic surgery and procedure market is expected to reach USD 44.0 billion by 2025.
 
Track25: Stem Cells in Obstetrics and Gynecology
 
Stem cell based therapies hold promise for the obstetrician and gynecologist. Currently, mesenchymal and muscle-derived stem cells are being explored for the treatment of urinary and anal incontinence. Potential stem cell treatments include fistula repair, vaginal tissue engineering, and graft material enhancement. Recent reports have pointed out the importance of timing in prenatal stem cell transplantation procedures and have shown the advantage of an early stem cell injection. Stem cell banking is one of the most happening markets in the field of life sciences. A stem cell bank is a service that preserves stem cells for the treatment of life-threatening diseases in the future. Global Stem Cell Banking Market is accounted for $1.69 billion in 2016 and is expected to reach $5.62 billion by 2023 growing at a CAGR of 18.9% during the forecast period.
 
Track26: Pediatric and Adolescent Gynecology
 
Pediatric gynaecology or is the medical practice dealing with the health of the vagina, vulva, uterus, and ovaries of infants, children, and adolescents. Paediatrics is the branch of medicine that involves the medical care of infants, children, and adolescents. Adolescent medicine or hebiatrics is a medical subspecialty that focuses on care of patients who are in the adolescent period of development, generally ranging from the last years of elementary school until graduation from high school. The global Pediatric healthcare products and services market was expanding at a CAGR of around 4.6% and 5.6%, respectively, from 2018 to 2025.

Market Report

EuroSciCon invites participants from across the globe to join the “EuroSciCon Conference on Gynecology, Obstetrics & Reproductive Health” going to be held during June 7-8, 2019, Paris, France. The conference includes Keynote Presentations, Oral Talks, Poster Presentations, Product Launches and Exhibitions. Euro Gynecology 2019 is a specially designed cluster conference, whose main theme is “Technical Strategies in Pre-natal grief, Child Birth and Congenital Disorders”. This event covers a wide spectrum of critically important sessions.
For more details please visit: https://gynecology.euroscicon.com/
 
Importance & Scope:
Obstetrics and gynecology is the medical specialty that deals with obstetrics and gynecology. Postgraduate training programs for both aspects are usually combined, preparing the practising obstetrician-gynaecologist to be adept at the care of female reproductive organs' health and at the management of pregnancy, although many doctors go on to develop subspecialty interests in one field or the other.
Birthing specialists have a vital part in wellbeing and health advancement and training for the lady, her family and the group. Maternity care rehearse includes illuminating and setting up the lady and her family for pregnancy, birth, breastfeeding and parenthood and incorporates certain parts of ladies' wellbeing, family arranging and newborn baby prosperity.
The conference will provide exceptional opportunities for Delegates from Universities and Institutes to interact with world-class Scientists and Industrial Professionals working in the field of Obstetrics and gynecology. Euro Gynaecology 2019 will explore new ideas and advancements on a global scale in topics like Gynecology, Obstetrics & Reproductive Health, Gynaecology and Obstetrics pathology, Recent advances in gynaecology, Medical complication in pregnancy, Urogenital system of human, Gynaecological Endocrinology, Stem Cells in Obstetrics and Gynecology, Minimally Invasive Gynecologic Surgery, Midwifery, Sexual and reproductive health rights, Normal Pregnancy, Labour & Puerperium, Clinical Gynecologic Oncology, Robotic Surgery in Gynecologic Oncology, Polycystic Ovary Syndrome, Cosmetic Gynaecology, Reproductive Medicine, Medicated Intrauterine Devices & Ultrasound and Genetics.
 
Market Analysis Report:
Healthcare industries have experienced strong growth over the past six years, the Gynecologists and Obstetricians industry has grown at a more muted pace. While demand for most healthcare services is based mainly on access to health insurance, ob-gyn services have such a necessary place in women's health that demand is steady for this industry.
The Gynecology & obstetrics market report provides in detailed study i. e. Durability, weak point, opportunity, competitors etc. Gynecology surgical instruments industry report provides an in detail study of Manufactures in the market which is based on the various objectives associated with an organization such as analysis, regional market performance, product specification and the company introduction.
Gynecology surgical forceps market report gives SWOT analysis for new entrants and interested investors and the viability of investment analysis for new investors of gynecology surgical forceps market. Overall, each type of stakeholder can be benefited from this report as this research covers all major aspects of the gynecology surgical forceps market.
In the global gynecology surgical instruments industry market analysis & forecast 2018–2022, the revenue is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2018 and 2022. The production is estimated at XX million in 2018 and is forecasted to reach XX million by the end of 2022, growing at a CAGR of XX% between 2018 and 2022.
The global gynecology devices market size was valued at USD 7.8 billion in 2017 and is expected to grow at a CAGR of 15.8% during the forecast period. Introduction of advanced devices which aid in increasing the efficiency of minimally invasive procedures and high development of definition imaging devices such as the 3D endoscope is primarily boosting the market growth.

Learn More

Major Gynecology and Obstetrics Associations around the Globe:
 
 
Related Associations in Gynecology & Obstetrics:
 
 
List of Top Hospitals in France:
 
List of Hospitals in Paris:
 
List of Top Hospitals in World:
 
University of Michigan Hospitals-Michigan Medicine | Memorial Sloan-Kettering Cancer Center | Johns Hopkins Hospital | UCSF Medical Center | Stanford Health Care-Stanford Hospital | Vanderbilt University Medical Center | Massachusetts General Hospital | University of Wisconsin Hospitals | Barnes-Jewish Hospital | Northwestern Memorial Hospital | Pennsylvania Hospital | University of California, Davis Medical Center | Brigham and Women's Hospital | St. Joseph's Hospital and Medical Center | United Hospital | Nebraska Medicine-Nebraska Medical Center | Cedars-Sinai Medical Center | Mount Sinai Hospital | Keck Hospital of USC | John Muir Health-Walnut Creek Medical Center | New York-Presbyterian Hospital-Columbia and Cornell | Dartmouth-Hitchcock Medical Center | University of Washington Medical Center | City of Hope Helford Clinical Research Hospital | University of Chicago Medical Center | St. Elizabeth Healthcare Edgewood-Covington Hospitals | OHSU Hospital.
 
Supported Journals for Obstetrics & Gynecology:
 
 
Obstetrics & Gynecology Societies:
 
 
List of Major Conferences Related to Gynecology in World:
 
 
The glance at Income of Ob Gyn’s:
 
The global gynecological devices market is treading a growth path on the back of rising incidence of gynecological disorders such as fibroids and cervical cancer. The global market for gynecological devices is likely to register a CAGR of 4.9% between 2018 and 2023.
Rising preference for minimally invasive gynecological procedures along with recent advances in conventional endoscopic surgeries bode well for surgical devices segment. The surgical devices market is projected to be worth US$414, 959.8 mn by 2023.

Euro Gynecology 2018 Report

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Euro Gynecology 2018 Conference the successful!

Annual Conference on Euro Gynecology 2018, hosted by the EuroSciCon Ltd. was held during August 23-24, 2018 at Hotel Hyatt Place Amsterdam Airport, Netherlands based on the theme “Technical Strategies in Pre-natal grief, Child Birth and Congenital Disorders" which got the magnificent response. With the support and guidance of Organizing Committee Members and Editorial Board Members and astonish presentations of all participants along with Scientists, Researchers, Students and leaders from various fields of Clinical Research made this event a grand success.

EuroSciCon Ltd expresses its gratitude to the conference Moderator, namely Dr. Christos Tsitlakidis, Pinderfields Hospital, UK for taking up the responsibility to coordinate during the sessions for the smooth functioning of this event. We are indebted to your support. We hope you continue your support in our future endeavours. The conference was initiated with the Honourable presence of the Keynote forum. The speaker's list includes:

Dr. Christos Tsitlakidis, Pinderfields Hospital, UK

Dr. Ioannis G. Papanikolaou, University of Athens Medical School, Greece

Dr. Mircea Onofriescu, University of Medicine Grigore T Popa, Romania

Dr. Masahiro Onuma, Trisguide ltd, Japan

Dr Jessica E. van der Aaa, OLVG Hospital, Amsterdam, the Netherlands

Dr. Madelon Van Wely, University of Amsterdam, Netherlands

Grace O. Daniel, University of Jos, Nigeria

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Gynaecology and Obstetrics Pathology
Cosmo Gynecology Surgery
Prenatal Diagnosis of Chromosomal Abnormalities
Recent Advances in Gynaecology
Medical Complication in Pregnancy
Gynaecological Endocrinology
Reproductive Medicine
Urinary Incontinence (UI)
Robotic Surgery In Gynecologic Oncology
Clinical Gynecologic Oncology
Infertility
Midwifery
Amenorrhoea
Menopause
Polycystic Ovary Syndrome
Normal Pregnancy, Labour & Puerperium
Sexual and Reproductive Health Rights

EuroSciCon Ltd also took the privilege of felicitating Euro Gynecology 2018 Organizing Committee, Editorial Board Members of Biomarkers Journal and Annals of Clinical and Laboratory Research Journal, Keynote Speakers, Chair and Co-Chairs, Moderator who supported this event. With the grand success of Euro Gynecology 2018, EuroSciCon Ltd is proud to announce the “EuroSciCon Conference on Gynecology, Obstetrics & Reproductive Health” to be held soon.

For More details visit: https://gynecology.euroscicon.com/

 

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!